In the pharmaceutical sector the need for a product recall can ultimately be a matter of life or death. Product recalls are extremely costly to the pharmaceutical industry: the financial implications, not to mention the inevitable damage to a company's safety reputation can have long-standing consequences. In response to an evolving regulatory climate and continually emerging best practice guidelines, Smithers Rapra's 2009 Leachables & Extractables for Pharmaceutical Products conference aims to ensure shared understanding of current leachables and extractables developments throughout the industry, to ensure that such instances are avoidable.
The Smithers Group is building on the success of the Leachables & Extractables Conference held in Dublin this March by organising a similar conference in 2009.
Smithers Rapra is recruiting papers from experts and companies that have established best practice in the field of leachables & extractables. By presenting a paper at this conference, organisations can ensure that their name is firmly positioned at the forefront of Leachables & Extractables activity and have the opportunity to present to all parts of the pharmaceutical supply chain. The specific topics that the industry has called for more information on include; current regulatory climate, future regulation and its impact for pharmaceutical manufacturers and component suppliers, case studies from industry, initiatives and progresses, phase appropriate L & E evaluation, application of quality by design, testing and control strategies and maintaining proprietary information.
22-Oct-08 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}